EWM
TMDX icon

Evolution Wealth Management’s Transmedics TMDX Stock Holding History

Evolution Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.24K Buy
94
+40
+74% +$3.39K ﹤0.01% 662
2026
Q1 		$5.37K Hold
54
– – ﹤0.01% 611
2025
Q4 		$6.57K Buy
+54
New +$6.78K 0.01% 502

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Evolution Wealth Management's TMDX Position: Q2 2026 in Review

Evolution Wealth Management increased its Transmedics (TMDX) stake by 74% in Q2 2026, buying an estimated $3.39K and bringing the position to 94 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Evolution Wealth Management first reported a position in TMDX in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.57K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Evolution Wealth Management held 94 shares of Transmedics worth $6.24K as of Q2 2026.
  • Evolution Wealth Management bought 40 Transmedics shares in Q2 2026, an estimated $3.39K.
  • Transmedics made up ﹤0.01% of Evolution Wealth Management's portfolio in Q2 2026, its #662 holding.
  • Evolution Wealth Management first reported a position in Transmedics in Q4 2025 and has held it in 3 quarters since.
  • Evolution Wealth Management's Transmedics position peaked at $6.57K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.